Literature DB >> 23032450

Acute pulmonary exacerbations of sarcoidosis.

Efstratios Panselinas1, Marc A Judson2.   

Abstract

Exacerbations of sarcoidosis are common. In particular, exacerbations of pulmonary sarcoidosis are reported in more than one-third of patients. Despite their frequent occurrence, there is little medical evidence concerning the definition, diagnosis, and treatment of pulmonary exacerbations of sarcoidosis. In this article, we propose a definition of acute pulmonary exacerbations of sarcoidosis (APES). We review the meager medical literature concerning the risk factors, diagnosis, and treatment of this condition. Given the limited information concerning APES, we acknowledge that this article is not a definitive resource but, rather, a position paper that will encourage greater consideration of the pathogenesis, diagnostic challenges, and treatment approaches to this condition. We believe that further focus on APES will improve the quality of care of patients with pulmonary sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23032450     DOI: 10.1378/chest.12-1060

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  18 in total

Review 1.  Morbidity and mortality in sarcoidosis.

Authors:  Alicia K Gerke
Journal:  Curr Opin Pulm Med       Date:  2014-09       Impact factor: 3.155

Review 2.  The Clinical Features of Sarcoidosis: A Comprehensive Review.

Authors:  Marc A Judson
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

Review 3.  From granuloma to fibrosis: sarcoidosis associated pulmonary fibrosis.

Authors:  Catherine A Bonham; Mary E Strek; Karen C Patterson
Journal:  Curr Opin Pulm Med       Date:  2016-09       Impact factor: 3.155

4.  Simultaneous testing of immunological sensitization to multiple antigens in sarcoidosis reveals an association with inorganic antigens specifically related to a fibrotic phenotype.

Authors:  E Beijer; R Kraaijvanger; C Roodenburg; J C Grutters; B Meek; M Veltkamp
Journal:  Clin Exp Immunol       Date:  2020-10-06       Impact factor: 4.330

Review 5.  Advances in the diagnosis and treatment of sarcoidosis.

Authors:  Marc A Judson
Journal:  F1000Prime Rep       Date:  2014-10-01

6.  Risk of death in patients with progressive pulmonary sarcoidosis.

Authors:  Bargagli Elena; Torricelli Elena; Fusha Erjona; Cavigli Edoardo; Moroni Chiara; Pistolesi Massimo; Rosi Elisabetta; Voltolini Luca
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-03-09       Impact factor: 0.670

Review 7.  Challenges in Cardiac and Pulmonary Sarcoidosis: JACC State-of-the-Art Review.

Authors:  Maria Giovanna Trivieri; Paolo Spagnolo; David Birnie; Peter Liu; Wonder Drake; Jason C Kovacic; Robert Baughman; Zahi A Fayad; Marc A Judson
Journal:  J Am Coll Cardiol       Date:  2020-10-20       Impact factor: 24.094

8.  The Circulating Treg/Th17 Cell Ratio Is Correlated with Relapse and Treatment Response in Pulmonary Sarcoidosis Patients after Corticosteroid Withdrawal.

Authors:  Yongzhe Liu; Lan Qiu; Yanxun Wang; Halimulati Aimurola; Yuyue Zhao; Shan Li; Zuojun Xu
Journal:  PLoS One       Date:  2016-02-04       Impact factor: 3.240

9.  Cumulative Incidence and Predictors of Progression in Corticosteroid-Naïve Patients with Sarcoidosis.

Authors:  Yusuke Inoue; Naoki Inui; Dai Hashimoto; Noriyuki Enomoto; Tomoyuki Fujisawa; Yutaro Nakamura; Takafumi Suda
Journal:  PLoS One       Date:  2015-11-17       Impact factor: 3.240

10.  Short-Term Particulate Air Pollution Exposure is Associated with Increased Severity of Respiratory and Quality of Life Symptoms in Patients with Fibrotic Sarcoidosis.

Authors:  Cheryl S Pirozzi; Daniel L Mendoza; Yizhe Xu; Yue Zhang; Mary Beth Scholand; Robert P Baughman
Journal:  Int J Environ Res Public Health       Date:  2018-05-26       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.